Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2018	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Jan 1, 2018	Dec 31, 2016
Pharmaceuticals	1.39B	1.34B	1.15B	1.15B	1.09B
Pharmaceuticals Growth	4.18%	15.88%	0.56%	5.00%	-4.29%
Total	1.39B	1.34B	1.15B	1.15B	1.09B
Total Growth	4.18%	15.88%	0.56%	5.00%	-4.29%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2018	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Jan 1, 2018	Dec 31, 2016
Northern China	579.59M	497.76M	552.77M	496.66M	446.15M
Northern China Growth	16.44%	-9.95%	11.30%	11.32%	-9.15%
Northeast China	53.88M	61.17M	20.17M	25.07M	25.57M
Northeast China Growth	-11.93%	203.26%	-19.55%	-1.96%	2.01%
East China	322.92M	307.60M	224.86M	270.81M	241.41M
East China Growth	4.98%	36.80%	-16.97%	12.18%	-8.82%
South Central China	228.87M	280.25M	202.74M	160.64M	187.33M
South Central China Growth	-18.33%	38.23%	26.21%	-14.25%	-0.75%
Southwest China	119.22M	113.43M	90.83M	122.70M	126.51M
Southwest China Growth	5.10%	24.88%	-25.97%	-3.01%	12.92%
North-West China	84.85M	73.55M	58.91M	66.95M	60.95M
North-West China Growth	15.36%	24.86%	-12.01%	9.85%	14.72%
Export	2.68M	2.38M	2.75M	3.75M	4.02M
Export Growth	12.80%	-13.64%	-26.57%	-6.64%	-
Total	1.39B	1.34B	1.15B	1.15B	1.09B
Total Growth	4.18%	15.88%	0.56%	5.00%	-4.29%

Source: S&P Global Market Intelligence.